Discover 3 Swedish Growth Stocks With Significant Insider Ownership

Simply Wall St.
21 Oct 2024

As European markets respond positively to recent interest rate cuts by the European Central Bank, Swedish investors are keenly observing opportunities in growth stocks that may benefit from a more accommodative monetary environment. In this context, companies with high insider ownership can be particularly appealing as they often signal strong alignment between management and shareholder interests, potentially enhancing their resilience and growth potential in fluctuating market conditions.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name Insider Ownership Earnings Growth
CTT Systems (OM:CTT) 16.9% 24.8%
Truecaller (OM:TRUE B) 29.7% 21.7%
Magle Chemoswed Holding (OM:MAGLE) 8.8% 72.2%
Biovica International (OM:BIOVIC B) 18.3% 78.5%
BioArctic (OM:BIOA B) 34% 98.4%
Yubico (OM:YUBICO) 37.5% 42.2%
KebNi (OM:KEBNI B) 36.3% 86.1%
InCoax Networks (OM:INCOAX) 20.1% 115.5%
C-Rad (OM:CRAD B) 16.1% 33.9%
OrganoClick (OM:ORGC) 23.1% 109.0%

Click here to see the full list of 81 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

NIBE Industrier

Simply Wall St Growth Rating: ★★★★☆☆

Overview: NIBE Industrier AB (publ) develops, manufactures, markets, and sells energy-efficient solutions for indoor climate comfort and intelligent heating and control across Nordic countries, Europe, North America, and internationally with a market cap of approximately SEK101.45 billion.

Operations: The company's revenue segments include SEK5.33 billion from Stoves, SEK13.48 billion from Element, and SEK35.22 billion from Climate Solutions.

Insider Ownership: 20.2%

NIBE Industrier, with significant insider ownership, faces challenges despite expected annual earnings growth of 41.1%, surpassing the Swedish market's forecast. Recent financials show a decline in sales and net income, impacting profit margins at 3.6% compared to last year's 11.2%. Revenue is projected to grow at 6.7% annually, outpacing the Swedish market but falling short of high-growth benchmarks. The stock trades near its fair value estimate, with no substantial recent insider trading activity noted.

  • Dive into the specifics of NIBE Industrier here with our thorough growth forecast report.
  • The analysis detailed in our NIBE Industrier valuation report hints at an inflated share price compared to its estimated value.
OM:NIBE B Ownership Breakdown as at Oct 2024

Sectra

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Sectra AB (publ) offers medical IT and cybersecurity solutions across Sweden, the United Kingdom, the Netherlands, and other parts of Europe, with a market cap of approximately SEK56.34 billion.

Operations: The company generates revenue primarily from its Imaging IT Solutions segment, which accounts for SEK2.67 billion, and its Secure Communications segment, contributing SEK388.55 million.

Insider Ownership: 30.3%

Sectra, with high insider ownership, is experiencing robust growth prospects. Its earnings are forecast to grow significantly at 21.2% annually, outpacing the Swedish market's 15.5%. Recent financials reveal a strong performance with Q1 revenue rising to SEK 739.48 million from SEK 603.03 million year-on-year and net income increasing to SEK 80.4 million from SEK 61.56 million. The recent partnership with MaineGeneral Health underscores Sectra's strategic expansion in healthcare IT solutions globally.

  • Delve into the full analysis future growth report here for a deeper understanding of Sectra.
  • Insights from our recent valuation report point to the potential overvaluation of Sectra shares in the market.
OM:SECT B Ownership Breakdown as at Oct 2024

Surgical Science Sweden

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training globally, with a market cap of SEK6.61 billion.

Operations: The company's revenue is divided into Industry/OEM at SEK400.72 million and Educational Products at SEK437.53 million.

Insider Ownership: 26.6%

Surgical Science Sweden's insider ownership aligns with its strong growth trajectory, as earnings are projected to rise significantly at 32.6% annually, surpassing the Swedish market's growth. Despite a recent dip in Q2 financials, with sales at SEK 212.47 million and net income at SEK 28.57 million, the stock trades well below its estimated fair value. Revenue is expected to grow faster than the broader market but below significant growth thresholds.

  • Click to explore a detailed breakdown of our findings in Surgical Science Sweden's earnings growth report.
  • Upon reviewing our latest valuation report, Surgical Science Sweden's share price might be too pessimistic.
OM:SUS Ownership Breakdown as at Oct 2024

Make It Happen

  • Embark on your investment journey to our 81 Fast Growing Swedish Companies With High Insider Ownership selection here.
  • Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
  • Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Curious About Other Options?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:NIBE B OM:SECT B and OM:SUS.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10